Twist Bioscience to Report Fiscal 2024 Second Quarter Financial Results on Thursday, May 2, 2024
Twist Launches IVDR-compliant Precision Dx Products for Whole Exome Sequencing
Twist Bioscience to Present at Upcoming Investor Conferences
Twist Bio Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Twist Bio and Element Bio Collaborate on Exome Sequencing Solutions
Twist Bio Launches cfDNA Library Preparation Kit for Liquid Biopsy Applications
Twist Bio Unveils Differentiated Ultra High-Throughput Library Solution
Twist Bioscience Reports Fiscal First Quarter 2024 Financial Results
Twist Bioscience Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
Twist Bioscience to Present at 42nd Annual J.P. Morgan Healthcare Conference